Cyclophosphamide

interleukin 2 ; Mus musculus







59 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34949747 Immune-Enhancing Effects of Crude Polysaccharides from Korean Ginseng Berries on Spleens of Mice with Cyclophosphamide-Induced Immunosuppression. 2022 Feb 28 1
2 34128029 Alhagi honey polysaccharides attenuate intestinal injury and immune suppression in cyclophosphamide-induced mice. 2021 Aug 2 1
3 34840584 The Immunomodulatory Effects of Phellodendri Cortex Polysaccharides on Cyclophosphamide-Induced Immunosuppression in Mice. 2021 1
4 32306006 [Effect of Fei-Liu-Ping ointment combined with cyclophosphamide on lung cancer cell proliferation and acidic microenvironment]. 2020 Apr 18 1
5 32475918 Characterization and Immunological Activities of Polysaccharides from Polygonatum sibiricum. 2020 2
6 33266362 Immunostimulatory Effects of Live Lactobacillus sakei K040706 on the CYP-Induced Immunosuppression Mouse Model. 2020 Nov 22 1
7 30268651 Xinjiang herbal tea exerts immunomodulatory activity via TLR2/4-mediated MAPK signaling pathways in RAW264.7 cells and prevents cyclophosphamide-induced immunosuppression in mice. 2019 Jan 10 1
8 28939510 Characterization and protective effect of Polygonatum sibiricum polysaccharide against cyclophosphamide-induced immunosuppression in Balb/c mice. 2018 Feb 1
9 25708328 Chronodependent effect of interleukin-2 on mouse spleen cells in the model of cyclophosphamide immunosuppression. 2015 Feb 3
10 25785030 Effect of Chuanminshen violaceum polysaccharides and its sulfated derivatives on immunosuppression induced by cyclophosphamide in mice. 2015 1
11 23659474 Improving the in vivo persistence, distribution and function of cytotoxic T lymphocytes by inhibiting the tumor immunosuppressive microenvironment. 2013 Jul 1
12 21649551 Effect of millimeter waves and cyclophosphamide on cytokine regulation. 2012 Feb 1
13 22667143 [Study on extraction and immune regulation of polysaccharides from Marsdenia tenacissima]. 2012 Feb 1
14 22814394 SJSZ glycoprotein (38 kDa) modulates expression of IL-2, IL-12, and IFN-γ in cyclophosphamide-induced Balb/c. 2012 Dec 1
15 23000689 Cyclic adenosine monophosphate involvement in low-dose cyclophosphamide-reversed immune evasion in a mouse lymphoma model. 2012 Nov 2
16 21279551 Effect of zymosan on antioxidant and immune function of S180 tumor-bearing mice. 2011 Jul 1
17 19946662 Targeting of IL-2 receptor with a caspase fusion protein disrupts autoimmunity in prediabetic and diabetic NOD mice. 2010 Feb 1
18 18853118 Effect of Radix isatidis polysaccharides on immunological function and expression of immune related cytokines in mice. 2008 Sep 2
19 17255288 Cyclophosphamide enhances the antitumor efficacy of adoptively transferred immune cells through the induction of cytokine expression, B-cell and T-cell homeostatic proliferation, and specific tumor infiltration. 2007 Jan 15 1
20 10607705 Nitric oxide-producing CD11b(+)Ly-6G(Gr-1)(+)CD31(ER-MP12)(+) cells in the spleen of cyclophosphamide-treated mice: implications for T-cell responses in immunosuppressed mice. 2000 Jan 1 1
21 10089919 Paclitaxel vs cyclophosphamide in peripheral blood stem cell mobilization: comparative studies in a murine model. 1999 Mar 1
22 10464704 Enhanced antitumor immune responses of IL-2 gene-modified tumor vaccine by combination with IL-1 and low dose cyclophosphamide. 1999 Jun 1
23 9174132 Interleukin-2 increases intracellular glutathione levels and reverses the growth inhibiting effects of cyclophosphamide on B16 melanoma cells. 1997 May 1
24 9222281 Priming of the antitumor response promotes efficacy of interleukin-2 therapy. 1997 Jun 1
25 8706342 Immunization of non-obese diabetic (NOD) mice with glutamic acid decarboxylase-derived peptide 524-543 reduces cyclophosphamide-accelerated diabetes. 1996 Aug 1
26 8933279 Differential expression of ICAM-1 and LFA-1 versus L-selectin and VCAM-1 in autoimmune insulitis of NOD mice and association with both Th1- and Th2-type infiltrates. 1996 Oct 2
27 7600560 The addition of interleukin-2 to cyclophosphamide therapy can facilitate tumor growth of B16 melanoma. 1995 May 1
28 7622294 Correlation between the sensitivity or resistance to IL-2 and the response to cyclophosphamide of 4 tumors transplantable in the same murine host. 1995 Jul 17 1
29 7759164 Adoptive transfer of ex vivo-activated memory T-cell subsets with cyclophosphamide provides effective tumor-specific chemoimmunotherapy of advanced metastatic murine melanoma and carcinoma. 1995 May 16 1
30 7860617 Interleukin-2 gene therapy of residual EL-4 leukaemia potentiates the effect of cyclophosphamide pretreatment. 1995 2
31 7804526 Delivery of cytokines by liposomes. II. Interleukin-2 encapsulated in long-circulating sterically stabilized liposomes: immunomodulatory and anti-tumor activity in mice. 1994 Aug 1
32 7974716 The inhibitory effect of cyclophosphamide-induced MAC-1+ natural suppressor cells on IL-2 and IL-4 utilization in MLR. 1994 Nov 27 1
33 8010605 Melatonin restores immunodepression in aged and cyclophosphamide-treated mice. 1994 May 31 1
34 8168119 Chemotherapy-induced modulation of natural killer and lymphokine-activated killer cell activity in euthymic and athymic mice. 1994 Apr 2
35 8425189 Combined interleukin 1 beta/interleukin 2 treatment in mice: synergistic myelostimulatory activity and protection against cyclophosphamide-induced myelosuppression. 1993 Feb 1 1
36 1361881 Tumor-specific chemoimmunotherapy of murine fibrosarcoma using tumor-specific transplantation antigen, cyclophosphamide, and interleukin-2. 1992 1
37 1534792 Melatonin as immunomodulator in immunodeficient mice. 1992 Mar-Apr 1
38 1760819 Importance in timing of cyclophosphamide on the enhancement of interleukin-2-induced cytolysis. 1991 3
39 1835471 Interleukin-2 enhances the translocation of Escherichia coli from the intestines to other organs. 1991 Dec 4
40 1991327 Thymosin alpha 1 potentiates interleukin 2-induced cytotoxic activity in mice. 1991 Mar 1
41 1718146 Immune enhancement of a polysaccharides peptides isolated from Coriolus versicolor. 1990 Nov 1
42 2389941 [Experimental study on the optimal treatment schedule for combination of BRM (immunostimulators, cultured killer cells or interleukin-2) and chemotherapy]. 1990 Aug 1
43 2666309 Patterns of IL-2 production and utilization in mice heavily infected with Mycobacterium bovis BCG reflect the phase of protective immunity being expressed. 1989 Jun 1
44 2785003 Chemo-immunotherapy of murine tumors using interleukin-2 (IL-2) and cyclophosphamide. IL-2 can facilitate or inhibit tumor growth depending on the sequence of treatment and the tumor type. 1989 4
45 2895062 Lethal vaccinia infection in cyclophosphamide-suppressed mice is associated with decreased expression of Thy-1, Lyt-2 and L3T4 and diminished IL-2 production in surviving T cells. 1988 Mar 1
46 3257159 Combined effects of chemotherapy and interleukin 2 in the therapy of mice with advanced pulmonary tumors. 1988 Jan 1 4
47 3260132 Improved therapeutic effects of interleukin 2 after the accumulation of lymphokine-activated killer cells in tumor tissue of mice previously treated with cyclophosphamide. 1988 8
48 3264714 Efficacy of chemoimmunotherapy with cyclophosphamide, interleukin-2 and lymphokine activated killer cells in an intraperitoneal murine tumour model. 1988 Oct 1
49 2444243 Alloimmune cells consume interleukin-2 and competitively inhibit the anti-tumour effects of interleukin-2. 1987 Aug 1
50 2949833 In vivo resistance of secondary antitumor immune response to cyclophosphamide: effects on T cell subsets. 1987 3